Researchers have developed a novel antibody-based enzyme switch that converts antibody–antigen binding into enzyme activity, paving the way from detection via bioluminescence to the control of ...

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

The Beijing-based biotechnology company CorreGene was co-founded by Peking University alumni in 2016 to develop innovative T-cell receptor (TCR) therapies. CorreGene’s T-cell engager (TCE) pipeline ...

Goal of the ACS Service Center: The goal of the Antibody Characterization and Serology (ACS) Service Center is to offer research reagents, multiplex immunoassays and high-throughput technologies that ...

Bispecific antibodies (bispecifics) can simultaneously target two distinct antigens or epitopes, offering novel therapeutic strategies such as enhancing immune cell targeting of cancer cells or ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

A new discovery about how cells communicate with each other in the body’s immune system has revealed deeper insights for an international team of scientists into fundamental immune system function.

Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...